A Study of the Pharmacokinetics of Golimumab in Chinese Male Subjects

NCT01288157 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Chinese Males

Interventions

DRUG: Golimumab
DRUG: Golimumab

Sponsor

Centocor, Inc.